Identification of Inpatients at Risk for Poor Glycemic Control
1 other identifier
observational
33,011
1 country
1
Brief Summary
Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present at admission that identify patients at greater risk of poor inpatient glycemic control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 4, 2010
CompletedFirst Posted
Study publicly available on registry
January 6, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedApril 4, 2017
March 1, 2017
4.7 years
January 4, 2010
March 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hypoglycemia or hypoglycemia
during hospitalization
Study Arms (1)
Hospitalized patients
patients hospitalized at VUH between 4/1/2008 to 10/31/2009
Interventions
No interventions will be used in this study
Eligibility Criteria
Candidates for inclusion will include all adult (age ≥ 18 years) patients admitted to Vanderbilt University Medical Center from 04/01/2008 to 10/31/2009. Patients will be excluded if they were pregnant at the time of admission or had length of stay \< 24 hours.
You may qualify if:
- age ≥ 18 years
- hospitalized in VUH
You may not qualify if:
- length of stay \< 24 hours
- pregnant women
- patients receiving palliative/hospice care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Hospital
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Boord, MD MPH
Vanderbilt University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2010
First Posted
January 6, 2010
Study Start
January 1, 2010
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
April 4, 2017
Record last verified: 2017-03